Growth hormone(GH) is required for normal somatic growth and it also plays important roles in metabolism, immune function, and overall well being. A hypothalamic GH-releasing hormone (GHRH) deficit is now recognized as the primary cause of childhood onset GH deficiency and is linked to the lower circulating GH concentrations observed in elderly individuals. A variety of biopotent GHRH-like compounds are being developed for therapeutic use. However, relatively little is known about the regulation of endogenous GHRH synthesis and signaling. To better understand regulation of the GHRH/GHRH-receptor (GHRH-R) system this proposal focuses on counterregulatory mechanisms within the GH-axis which temper the pituitary somatotrope sensitivity to the actions of GHRH (homologous desensitization) and which regulate the availability of GHRH (GH/IGF-I negative feedback). Primary rat pituitary cell cultures will be used to study the effects of GHRH on GHRH-R synthesis (RT-PCR of GHRH-R mRNA) and sensitivity to GHRH (ligand stimulated adenylate cylase activity and cAMP generation). Studies will examine: ICER (cAMP inducible repressor), G-protein kinase-mediated receptor phosphorylation or receptor internalization roles in GHRH-mediated downregulation of the GHRH-R, in vitro. Animal models of aberrant GH production will examine the effects of GHRH hyper-(MT-hGHRH transgenic mice) and hypo-(monosodium glutamate treated rats) secretion on the GHRH-R signaling system, in vivo. Also, animal models will be used to determine 1) if circulating IGF-I plays an important role in hypothalamic feedback inhibition (GH receptor knockout mouse), 2) if GH induction of hypothalamic neuropeptide Y expression is an essential component of GH-mediated inhibition of GHRH synthesis (spontaneous dwarf rat [SDR] and TH-hGH transgenic dwarf mouse) and 3) if GH hypothalamic negative feedback contributes to diminished circulating GH concentrations observed with age (SDR). Finally, studies will be conducted to understand the relative contribution of the newly identified GH secretagogue receptor (GHS-R) system to the coordinate regulation of the GH-axis. The proposed studies represent a systematic approach to determine how counterregulatory mechanisms of the GH-axis maintain normal GHRH synthesis and signaling. A better understanding of these mechanisms will aid in the design and rational application of GHRH analogues and mimics which could serve to alleviate the deleterious effect of GH hyposecretion.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK030667-19
Application #
2905267
Study Section
Endocrinology Study Section (END)
Program Officer
Sato, Sheryl M
Project Start
1981-07-02
Project End
2001-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
19
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Illinois at Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Luque, Raul M; Gahete, Manuel D; Cordoba-Chacon, Jose et al. (2011) Does the pituitary somatotrope play a primary role in regulating GH output in metabolic extremes? Ann N Y Acad Sci 1220:82-92
Gahete, Manuel D; Cordoba-Chacon, Jose; Kineman, Rhonda D et al. (2011) Role of ghrelin system in neuroprotection and cognitive functions: implications in Alzheimer's disease. Peptides 32:2225-8
Cordoba-Chacon, Jose; Gahete, Manuel D; Duran-Prado, Mario et al. (2010) Identification and characterization of new functional truncated variants of somatostatin receptor subtype 5 in rodents. Cell Mol Life Sci 67:1147-63
Gahete, Manuel D; Cordoba-Chacon, Jose; Salvatori, Roberto et al. (2010) Metabolic regulation of ghrelin O-acyl transferase (GOAT) expression in the mouse hypothalamus, pituitary, and stomach. Mol Cell Endocrinol 317:154-60
Luque, Raul M; Soares, Beatriz S; Peng, Xiao-ding et al. (2009) Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation. Endocrinology 150:3177-85
Luque, Raul M; Park, Seungjoon; Kineman, Rhonda D (2008) Role of endogenous somatostatin in regulating GH output under basal conditions and in response to metabolic extremes. Mol Cell Endocrinol 286:155-68
Kim, E; Sohn, S; Lee, M et al. (2006) Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes. J Endocrinol 188:263-70
Sandoval, Raudel; Xue, Jiaping; Tian, Xinyong et al. (2006) A mutant allele of BARA/LIN-9 rescues the cdk4-/- phenotype by releasing the repression on E2F-regulated genes. Exp Cell Res 312:2465-75
Luque, Raul M; Duran-Prado, Mario; Garcia-Navarro, Socorro et al. (2006) Identification of the somatostatin receptor subtypes (sst) mediating the divergent, stimulatory/inhibitory actions of somatostatin on growth hormone secretion. Endocrinology 147:2902-8
Park, Seungjoon; Sohn, Sookjin; Kineman, Rhonda D (2004) Fasting-induced changes in the hypothalamic-pituitary-GH axis in the absence of GH expression: lessons from the spontaneous dwarf rat. J Endocrinol 180:369-78

Showing the most recent 10 out of 85 publications